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Reply to the Editor: 
Dr. Regragui and his colleagues report no difference in 
myocardial rewarming among three groups of patients 
undergoing hypothermic, moderately hypothermic, and 
normothermic cardiopulmonary b pass (CPB) perfusion. 
We 1 found a clinically small (mean temperature difference 
of 4.0 ° to 6.3 ° C) but significant enhancement of myocar- 
dial rewarming in our normothermic patients before 
redosing with cold blood cardioplegia. Although the sur- 
gical techniques used in both studies were similar (two- 
stage venous cannulation, single aortic crossclamping pe- 
riod), the cardioplegia composition and conduct were not 
identical. Both studies initiated electromechanical arrest 
with 1000 ml of 6 ° to 8 ° C crystalloid cardioplegic solution 
and achieved nearly identical (approximately 10 ° C) myo- 
cardial cooling in all groups. Thereafter our cardioplegia 
protocol included multidose cold (10 ° to 12°C) blood 
cardioplegia after construction of each distal anastomosis, 
which resulted in a mean temperature difference of 1.8 ° to 
4.0°C between the hypothermic and normothermic 
groups after each run of cardioplegia nd absolute myo- 
cardial temperatures of less than 17 ° C in both groups. Dr. 
Regragui's study redosed with colder crystalloid car- 
dioplegic solutions at 30-minute intervals or earlier if 
electrical activity occurred and achieved absolute myocar- 
dial temperatures of 18 ° to 20°C in all groups before 
removal of the aortic crossclamp. At that time both 
studies found no significant myocardial temperature dif- 
ferences between hypothermic and normothermic perfu- 
sion groups. Additionally, myocardial cooling was aug- 
mented in Dr. Regragui's patients with 1000 ml of ice-cold 
saline solution, a significantly greater volume than con- 
tained in our topical saline slush. These differences in 
cooling techniques most likely resulted in the observed 
differences in our findings. 
We note with gratification that the work described by 
Dr. Regragui and his associates confirms our findings that 
clinically protective levels of myocardial hypothermia can 
be maintained in patients undergoing normothermic CPB. 
The outcome data presented in their letter also support 
our findings that normothermic CPB will not compromise 
myocardial protection and result in post-CPB ventricular 
dysfunction if myocardial temperatures are maintained 
sufficiently cold. 
Arthur A. Bert, MD 
Providence, RI 02903 
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Surgical management for metachronous 
bronchogenic ancer occurring after 
pneumonectomy 
To the Editor: 
It is with greatest interest hat we perused the outstand- 
ing report on resection of metachronous bronehogenic 
cancers on single lungs, which has been published by Dr. 
Westermann and colleagues. 1 We would like to share our 
experience, although it is less extensive, inasmueh as we 
dealt with only four similar patients during the past 7 
years. 
All four patients were men, with ages ranging from 51 
to 61 years (Table I), and had strong smoking histories. 
Pneumonectomy had been done beeause of squamous eell 
caneer: stage I in one patient and stage II in three 
patients. One of them had undergone postoperative ra- 
diotherapy because of in situ earcinoma involvement of 
the reseetion margin. The second cancers were follow-up 
diagnoses at an interval ranging from 12 to 71 months. 
The staging procedure (cõmputed tomographic [CT] scan 
of head, chest, and abdomen; abdominal ultrasonography, 
and technetium bone scan) did not reveal distant metas- 
tases. Postoperative forced expiratory volume in 1 second 
(FEV1) was predicted to exceed 1 L in all patients. Three 
patients were operated on through a median sternotomy: 
a regular middle lobectomy was done in two and a 
segmental resection of the lingula in one. The fourth 
patient underwent a wedge resection through a short 
muscle-sparing lateral thoracotomy. In this particular 
case, we were able to block the right upper lobe bronchus 
with a balloon catheter positioned under bronchoscopic 
guidance. Only two patients had a smooth postoperative 
outcome. Two others, both operated on through amedian 
sternotomy, had respiratory failure and required transient 
tracheostomy. Their discharge from the hospital was 
delayed until postoperative days 27 and 65, respectively. 
On January 1, 1994, two patients were alive and well at 
5 and 67 months after operation. A third patient died 5 
months after resection of the lingula with brain metasta- 
ses. The fourth patient had a third malignancy in the right 
upper lobe 10 months after middle lobectomy and re- 
ceived focal radiotherapy; he remained in eomplete remis- 
sion until his death from an unrelated cause 29 months 
after operation (Table II). 
We may consider that all four patients had metachro- 
nous cancer, because their tumors occurred at least 6 
months after treatment of a first lesion. 2 However, only 
one of them had a tissue diagnosis that was different from 
the first cancer. We have to admit that the distinction 
from a single metastasis  nearly impossible. Preoperative 
work-up was limited to screening for distant metastases. 
3 In our standard staging described previously, we perform 
mediastinoscopy only when mediastinal CT scanning re- 
veals contralateral denomegaly. None of the patients in 
the present series underwent mediastinoscopy. Perhaps it 
should be considered routinely in these particular cases, in 
which mediastinal dissection during the procedure is 
necessarily shortened and incomplete in cases of an 
anterior approach. 
It is generally admitted that surgical resection isthe best 
treatment option for metachronous bronchogenic an- 
eer. 2'4 However, whenever the first cancer has been 
